Price Geoffrey M's Form 4 filing
Oak Street Health, Inc. (OSH) · filed Feb 23, 2023
- Accession no.
- 0001209191-23-012377
- Filed
- Feb 23, 2023
- Trade date
- Feb 21-22, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.15M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Price Geoffrey MCIK 0001793313 | Director, Officer (Chief Innovation Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Common Stock, $0.001 par value | MOption exerciseAcquired | +50,000 | $21.00 | +$1,050,000 | 3,924,863 | Direct | |
| Feb 21, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −50,000 | $35.32F2 | −$1,766,000 | 3,874,863 | Direct | |
| Feb 22, 2023 | Common Stock, $0.001 par value | MOption exerciseAcquired | +122,985 | $21.00 | +$2,582,685 | 3,997,848 | Direct | |
| Feb 22, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −122,985 | $35.61F3 | −$4,379,495.85 | 3,874,863 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Common Stock, par value $0.001 | MOption exerciseDisposed | −50,000 | $21.00 | −$1,050,000 | 2,091,868 | Direct | |
| Feb 22, 2023 | Common Stock, par value $0.001 | MOption exerciseDisposed | −122,985 | $21.00 | −$2,582,685 | 1,968,883 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.265 to $35.375, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (2).
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.600 to $35.640, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (3).
Referenced by the price of 1 transaction in Table I.